BBLG
Bone Biologics Corp
NASDAQ: BBLG · HEALTHCARE · BIOTECHNOLOGY
$1.31
+0.38% today
Updated 2026-04-30
Market cap
$2.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $7
Volume
0.0M
Bone Biologics Corp (BBLG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | $3000.00 | $3000.00 | $3000.00 | — | — | $877776.00 | $4451.00 | $700.00 | $96.00 | $96.00 | $50.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Gross profit | — | $-3000.00 | $-3000.00 | $-3000.00 | — | — | $-877776.00 | $-4451.00 | $-700.00 | $-96.00 | $-96.00 | $-50.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | $255.00 | $188236.00 | $623522.00 | $3.67M | $11.60M | $1.19M | $104490.00 | $1.10M | $340672.00 | $82044.00 | $1.58M | $6.91M | $2.13M | $1.06M |
| SG&A | — | — | — | — | $180.00 | $483749.00 | $1.51M | $8.33M | $6.25M | $3.82M | $2.69M | $1.35M | $484342.00 | $1.02M | $2.09M | $2.52M | $2.09M | $2.17M |
| Operating income | $-13343.00 | $-3000.00 | $-3000.00 | $-3000.00 | $-5231.00 | $-672000.00 | $-3.01M | $-12.00M | $-20.41M | $-2.63M | $-2.79M | $-2.45M | $-825014.00 | $-1.10M | $-3.67M | $-9.43M | $-4.22M | $-3.23M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-13343.00 | $-3000.00 | $-3000.00 | $-3000.00 | $-5231.00 | $-4806.00 | $-3.02M | $-11.99M | $-20.41M | $-2.63M | $-2.79M | $-2.45M | $-825014.00 | $-803976.00 | $-752906.00 | $479572.00 | $107161.00 | $-3.11M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-13343.00 | $-3000.00 | $-3000.00 | $-3000.00 | $-5666.00 | $-676791.00 | $-3.02M | $-12.00M | $-20.41M | $-2.63M | $-2.79M | $-2.45M | $-825014.00 | $-1.10M | $-8.06M | $-8.95M | $-4.11M | — |
| Interest expense | — | — | — | — | — | — | $1.40M | $1.87M | $2.62M | $4.42M | $1.23M | $975774.00 | $998076.00 | $805109.00 | $731714.00 | $2.18M | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13343.00 | — | — | — | $-715.00 | $-1.08M | $-4.42M | $-13.88M | $-25.88M | $-7.05M | $-4.43M | $-3.42M | $-1.82M | $-1.61M | $-1.48M | $-8.95M | $-4.11M | $-3.11M |
| Net income growth (YoY) | — | +100.0% | — | — | — | -151228.7% | -308.9% | -213.7% | -86.5% | +72.8% | +37.2% | +22.7% | +46.7% | +11.7% | +7.8% | -502.8% | +54.1% | +24.4% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |